{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:21:29Z","timestamp":1788200489333,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neuro.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:42:03Z","timestamp":1747309323000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pharmacological effects and pharmacokinetics of the novel synthetic cathinone \u03b1-pyrrolidinoisohexanophenone (\u03b1-PiHP) compared with \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) in mice"],"prefix":"10.1016","volume":"108","author":[{"given":"Anne Marte","family":"Baarset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Synne","family":"Steinsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Nerem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannike M\u00f8rch","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-0624","authenticated-orcid":false,"given":"Inger Lise","family":"Bogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.neuro.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","article-title":"In vivo potency and efficacy of the novel cathinone \u03b1-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuro.2025.05.005_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.legalmed.2019.101626","article-title":"A case of intoxication with a new cathinone derivative \u03b1-PiHP - a presentation of concentrations in biological specimens","volume":"42","author":"Adamowicz","year":"2020","journal-title":"Leg. Med (Tokyo)"},{"issue":"4","key":"10.1016\/j.neuro.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","article-title":"Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery","volume":"2","author":"Alavijeh","year":"2005","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.neuro.2025.05.005_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1124\/jpet.109.152462","article-title":"Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo","volume":"331","author":"Andersen","year":"2009","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neuro.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2007.03.078","article-title":"Procedure of rectal temperature measurement affects brain, muscle, skin, and body temperatures and modulates the effects of intravenous cocaine","volume":"1154","author":"Bae","year":"2007","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuro.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.110.176271","article-title":"In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat","volume":"337","author":"Baumann","year":"2011","journal-title":"J. Pharm. Exp. Ther."},{"issue":"4","key":"10.1016\/j.neuro.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuro.2025.05.005_bib8","series-title":"New psychoactive substances","first-page":"113","article-title":"Neuropharmacology of synthetic cathinones","volume":"252","author":"Baumann","year":"2018"},{"issue":"4-5","key":"10.1016\/j.neuro.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0197-0186(03)00027-5","article-title":"Short- and long-term effects of MDMA (\"ecstasy\") on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo","volume":"43","author":"Bogen","year":"2003","journal-title":"Neurochem. Int"},{"issue":"1","key":"10.1016\/j.neuro.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annemergmed.2012.01.005","article-title":"Hyperthermia and multiorgan failure after abuse of \"bath salts\" containing 3,4-methylenedioxypyrovalerone","volume":"60","author":"Borek","year":"2012","journal-title":"Ann. Emerg. Med"},{"key":"10.1016\/j.neuro.2025.05.005_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkae011","article-title":"\u03b1-Pyrrolidinohexanophenone (\u03b1-PHP) vs. \u03b1-pyrrolidinoisohexanophenone (\u03b1-PiHP): a toxicological investigation about plasma concentrations and behavior in forensic routine cases","author":"Brueckner","year":"2024","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.neuro.2025.05.005_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2011.10.002","article-title":"3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online","volume":"208","author":"Coppola","year":"2012","journal-title":"Toxicol. Lett."},{"issue":"12","key":"10.1016\/j.neuro.2025.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121793","article-title":"Natural sympathomimetic drugs: from pharmacology to toxicology","volume":"12","author":"Costa","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.neuro.2025.05.005_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF02249342","article-title":"Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d) in rats","volume":"114","author":"Dafters","year":"1994","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"7","key":"10.1016\/j.neuro.2025.05.005_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076230","article-title":"Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review","volume":"24","author":"Daziani","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.neuro.2025.05.005_bib16","unstructured":"Derendorf, H., Schmidt, S., 2019. Rowland and Tozer's clinical pharmacokinetics and pharmacodynamics: concepts and applications, fifth ed. Wolters Kluwer. ISBN: 9781496385901."},{"issue":"4","key":"10.1016\/j.neuro.2025.05.005_bib17","article-title":"\u03b1-Pyrrolidinohexanophenone (\u03b1-PHP) and \u03b1-Pyrrolidinoisohexanophenone (\u03b1-PiHP): a review","volume":"14","author":"Dinis","year":"2024","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.neuro.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release","volume":"360","author":"Eshleman","year":"2017","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.neuro.2025.05.005_bib19","unstructured":"European Monitoring Centre for Drugs and Drug Addiction & Europol, 2017. EMCDDA - Europol 2016 Annual Report on the Implementation of Council Decision 2005\/387\/JHA (TDAN17001ENN). https:\/\/www.doi.org\/10.2810\/430586."},{"key":"10.1016\/j.neuro.2025.05.005_bib20","unstructured":"European Monitoring Centre for Drugs and Drug Addiction & Europol, 2024. EU Drug Market: New psychoactive substances - In depth analysis. Distribution and supply in Europe: Synthetic cathinones (TD-02-24-350-EN-Q). https:\/\/www.euda.europa.eu\/publications\/eu-drug-markets\/new-psychoactive-substances_en."},{"key":"10.1016\/j.neuro.2025.05.005_bib21","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, 2022. New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (June 2022) (TD0522113ENN). https:\/\/www.doi.org\/10.2810\/396103."},{"issue":"12","key":"10.1016\/j.neuro.2025.05.005_bib22","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"Pt A","key":"10.1016\/j.neuro.2025.05.005_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.09.004","article-title":"Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice","volume":"134","author":"Gannon","year":"2018","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuro.2025.05.005_bib24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00213-017-4562-4","article-title":"Locomotor activity and discriminative stimulus effects of a novel series of synthetic cathinone analogs in mice and rats","volume":"234","author":"Gatch","year":"2017","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"7","key":"10.1016\/j.neuro.2025.05.005_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00213-014-3755-3","article-title":"Discriminative and locomotor effects of five synthetic cathinones in rats and mice","volume":"232","author":"Gatch","year":"2015","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"7","key":"10.1016\/j.neuro.2025.05.005_bib26","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/acschemneuro.0c00797","article-title":"Eutylone and Its Structural Isomers Interact with Monoamine Transporters and Induce Locomotor Stimulation","volume":"12","author":"Glatfelter","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuro.2025.05.005_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2017.10.022","article-title":"Effect fingerprinting of new psychoactive substances (NPS): what can we learn from in vitro data?","volume":"182","author":"Hondebrink","year":"2018","journal-title":"Pharm. Ther."},{"issue":"15","key":"10.1016\/j.neuro.2025.05.005_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158277","article-title":"The pharmacological profile of second generation pyrovalerone cathinones and related cathinone derivative","volume":"22","author":"Kolaczynska","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuro.2025.05.005_bib29","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1021\/acschemneuro.5b00160","article-title":"Structural modification of the designer stimulant \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) influences potency at dopamine transporters","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuro.2025.05.005_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2024.112297","article-title":"Findings of synthetic cathinones in post-mortem toxicology","volume":"365","author":"Kriikku","year":"2024","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.neuro.2025.05.005_bib31","article-title":"Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling","volume":"145","author":"Liechti","year":"2015","journal-title":"Swiss Med Wkly"},{"issue":"13","key":"10.1016\/j.neuro.2025.05.005_bib32","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1523\/JNEUROSCI.18-13-05086.1998","article-title":"Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat","volume":"18","author":"Malberg","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2025.05.005_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntt.2021.106977","article-title":"Assessment of aversive effects of methylone in male and female Sprague-Dawley rats: Conditioned taste avoidance, body temperature and activity\/stereotypies","volume":"86","author":"Manke","year":"2021","journal-title":"Neurotoxicol. Teratol."},{"issue":"3","key":"10.1016\/j.neuro.2025.05.005_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.neuro.2025.05.005_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \"bath salts\" constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1-3","key":"10.1016\/j.neuro.2025.05.005_bib36","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.forsciint.2009.05.012","article-title":"Brain biomarkers for identifying excited delirium as a cause of sudden death","volume":"190","author":"Mash","year":"2009","journal-title":"Forensic Sci. Int"},{"issue":"4","key":"10.1016\/j.neuro.2025.05.005_bib37","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/jm050797a","article-title":"1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors","volume":"49","author":"Meltzer","year":"2006","journal-title":"J. Med Chem."},{"issue":"3","key":"10.1016\/j.neuro.2025.05.005_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-007-1061-z","article-title":"The effects of methamphetamine on core body temperature in the rat--part 1: chronic treatment and ambient temperature","volume":"198","author":"Myles","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuro.2025.05.005_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.749429","article-title":"Structure-activity relationship of novel second-generation synthetic cathinones: mechanism of action, locomotion, reward, and immediate-early genes","volume":"12","author":"Nadal-Gratac\u00f3s","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.neuro.2025.05.005_bib40","unstructured":"National Center for Biotechnology Information, 2024a. PubChem Compound Summary for CID 59809191, 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one. Retrieved 02. December 2024 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/59809191."},{"key":"10.1016\/j.neuro.2025.05.005_bib41","unstructured":"National Center for Biotechnology Information, 2024b. PubChem Compound Summary for CID 11148955, alpha-Pyrrolidinovalerophenone. Retrieved 2. December 2024 from https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/11148955."},{"key":"10.1016\/j.neuro.2025.05.005_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/7854_2016_18","article-title":"Decoding the structure of abuse potential for new psychoactive substances: structure-activity relationships for abuse-related effects of 4-substituted methcathinone analogs","volume":"32","author":"Negus","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neuro.2025.05.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172762","article-title":"Sex differences in \u03b1-pyrrolidinopentiophenone (\u03b1-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats","volume":"185","author":"Nelson","year":"2019","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.neuro.2025.05.005_bib44","article-title":"Characterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method","author":"Persson","year":"2023","journal-title":"Drug Test. Anal."},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12906","article-title":"Naphyrone (naphthylpyrovalerone): pharmacokinetics, behavioural effects and thermoregulation in Wistar rats","volume":"26","author":"Pinterova-Leca","year":"2021","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.neuro.2025.05.005_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neuro.2025.05.005_bib47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s002130051022","article-title":"Self-administration of cocaine analogs by rats","volume":"144","author":"Roberts","year":"1999","journal-title":"Psychopharmacol. (Berl.)"},{"issue":"5","key":"10.1016\/j.neuro.2025.05.005_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/02698811221142566","article-title":"Comparison of locomotor stimulant and drug discrimination effects of four synthetic cathinones to commonly abused psychostimulants","volume":"37","author":"Shetty","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib49","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharm."},{"issue":"15","key":"10.1016\/j.neuro.2025.05.005_bib50","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/acs.jmedchem.5b00201","article-title":"Volume of distribution in drug design","volume":"58","author":"Smith","year":"2015","journal-title":"J. Med Chem."},{"issue":"5","key":"10.1016\/j.neuro.2025.05.005_bib51","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/adb.12399","article-title":"Cocaine-like discriminative stimulus effects of alpha-pyrrolidinovalerophenone, methcathinone and their 3,4-methylenedioxy or 4-methyl analogs in rhesus monkeys","volume":"22","author":"Smith","year":"2017","journal-title":"Addict. Biol."},{"issue":"6","key":"10.1016\/j.neuro.2025.05.005_bib52","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15563650.2011.590812","article-title":"Clinical experience with and analytical confirmation of \"bath salts\" and \"legal highs\" (synthetic cathinones) in the United States","volume":"49","author":"Spiller","year":"2011","journal-title":"Clin. Toxicol. (Philos.)"},{"key":"10.1016\/j.neuro.2025.05.005_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108910","article-title":"Effects of \u03b1-pyrrolidino-phenone cathinone stimulants on locomotor behavior in female rats","volume":"227","author":"Taffe","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.neuro.2025.05.005_bib54","article-title":"Management of Suspected \u03b1-Pyrrolidinoisohexanophenone (\u03b1-PiHP)-Related Hyperthermia in a Young Adult: A Case Report","volume":"16","author":"T'Kind","year":"2024","journal-title":"Cureus"},{"issue":"21","key":"10.1016\/j.neuro.2025.05.005_bib55","doi-asserted-by":"crossref","first-page":"12002","DOI":"10.3390\/ijms222112002","article-title":"Comparative neuropharmacology and pharmacokinetics of methamphetamine and its thiophene analog methiopropamine in rodents","volume":"22","author":"Tuv","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuro.2025.05.005_bib56","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/15563650.2016.1166508","article-title":"Clinical characteristics of \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) poisoning","volume":"54","author":"Umebachi","year":"2016","journal-title":"Clin. Toxicol. (Philos.)"},{"key":"10.1016\/j.neuro.2025.05.005_bib57","unstructured":"United Nations Office on Drugs and Crime, 2023a. May 2023 \u2013 UNODC: Update on \u03b1-PiHP: control status, emergence, use, detection, and identification. UNODC Laboratory and Scientific Service Portals. Retrieved 27. May 2024 from https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/732393de-cdd8-47c2-9af0-01d3ab4a305e#_ftnref3."},{"key":"10.1016\/j.neuro.2025.05.005_bib58","unstructured":"United Nations Office on Drugs and Crime, 2023b. March 2023 \u2013 UNODC: Seven NPS \"scheduled\" at the 66th Session of the Commission on Narcotic Drugs. UNODC Laboratory and Scientific Service Portals. Retrieved 27. May 2024 from https:\/\/www.unodc.org\/LSS\/Announcement\/Details\/933ced30-d982-4ed6-9fef-dee8afaffe47."},{"key":"10.1016\/j.neuro.2025.05.005_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkad026","article-title":"A fatal case of poisoning with a cathinone derivative: \u03b1-PiHP and its post-mortem distribution in body fluids and organ tissues","author":"Wachholz","year":"2023","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J. Pharm. Exp. Ther."},{"issue":"9","key":"10.1016\/j.neuro.2025.05.005_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1309\/WVX1-6FPV-E2LC-B6YG","article-title":"Evaluating sympathomimetic intoxication in an emergency setting","volume":"31","author":"Williams","year":"2000","journal-title":"Lab Med"},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11419-018-0409-x","article-title":"Effects of the new generation \u03b1-pyrrolidinophenones on spontaneous locomotor activities in mice, and on extracellular dopamine and serotonin levels in the mouse striatum","volume":"36","author":"Wojcieszak","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.neuro.2025.05.005_bib63","unstructured":"World Health Organization, 2022. Expert committee on drug dependence, forty-Fifth meeting. Critical review report: \u03b1-Pyrrolidinoisohexanophenone (\u03b1-PiHP). https:\/\/cdn.who.int\/media\/docs\/default-source\/controlled-substances\/45th-ecdd\/a-pihp-eh_sb_edit-1.pdf?sfvrsn=\u2009628a3f2f_1."},{"key":"10.1016\/j.neuro.2025.05.005_bib64","unstructured":"World Health Organization, 2023. WHO Expert committee on drug dependence: forty-fifth report (WHO Technical report series, No. 1046). https:\/\/www.who.int\/publications\/i\/item\/9789240068735."},{"issue":"8","key":"10.1016\/j.neuro.2025.05.005_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044652","article-title":"Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats","volume":"7","author":"Wright","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.31","article-title":"Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment","volume":"2","author":"Zaretsky","year":"2014","journal-title":"Pharm. Res Perspect."},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib67","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11419-021-00584-9","article-title":"Quantification and distribution of 4-fluoroisobutyryl fentanyl (4-FiBF) in postmortem biological samples using UHPLC\u2013QqQ-MS\/MS","volume":"39","author":"Zawadzki","year":"2021","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.neuro.2025.05.005_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2021.102287","article-title":"Severe poisoning after smoking a mixture of 4-fluoroisobutyryl fentanyl (4-FiBF) and alpha-pyrolidinoisohexaphenone (\u03b1-PiHP)","volume":"85","author":"Zawadzki","year":"2022","journal-title":"J. Forensic Leg. Med"},{"issue":"2","key":"10.1016\/j.neuro.2025.05.005_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11419-016-0353-6","article-title":"\u03b1-Pyrrolidinophenones: a new wave of designer cathinones","volume":"35","author":"Zawilska","year":"2017","journal-title":"Forensic Toxicol."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X25000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:41:13Z","timestamp":1778143273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X25000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":69,"alternative-id":["S0161813X25000567"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2025.05.005","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological effects and pharmacokinetics of the novel synthetic cathinone \u03b1-pyrrolidinoisohexanophenone (\u03b1-PiHP) compared with \u03b1-pyrrolidinovalerophenone (\u03b1-PVP) in mice","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}